(Updated - October 6, 2021 4:18 PM EDT)Jefferies analyst Akash Tewar assumes coverage on Sage Therapeutics (NASDAQ: SAGE) with a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE